The Bolivarian Republic of Venezuela has all the treatments that the people need, to face the Coronavirus (COVID-19), among these drugs is a peptide called Jusbinsa that fights inflammation, (which is a manifestation in people that become infected with the disease), and the drug Nasalferon, both from the Republic of Cuba, said the Venezuelan head of state, Nicolás Maduro, in a working meeting with the Presidential Commission for the Prevention and Control of COVID-19
Jusbinsa is a medicine for the most serious and critical cases, it has shown an effectiveness of 60% saving lives in the most critical cases, and of more than 92% of lives saved in the severe cases.
This response capacity of the country to combat this new virus is a reality “despite the fact that the United States government persecuted ships, companies, planes, so that treatments and medicines did not reach Venezuela, we managed to buy and bring to Venezuela all medicines that our people need for their treatment, and we are administering them.”
From the meeting held at the Miraflores Palace, the Venezuelan President emphasized that “sanctions and persecution with the complicity of the fugitive from justice, Guaido, are not valid, we defeated them on the subject of health and other issues.”
President Maduro said that the path taken to respond to the people has been possible thanks to cooperation with the republic of Cuba, from where two new medicines made in Cuba have arrived. “Treatments are coming, a preventive treatment and a curative treatment. Cuba is increasing productive capacity and these treatments are put at the service of the Venezuelan people. ”
In this regard, Julio García, head of the Cuban Medical Mission in Venezuela, added that in this way solidarity and brotherhood between Venezuela and Cuba are key, in the midst of a battle, a context “in which the peoples of Bolívar and Martí unite more every day.”
He pointed out that today Cuban science is available to humanity and is a “work that continues to advance, and is providing various important treatments that have been tested on critically ill patients in Cuba,” one of them is “a peptide that acts on cells and is called Jusbinsa and causes important possibilities of recovery in the human system,” since this medicine reduces inflammation of the lungs, bronchi or other organs, areas commonly affected in people who get COVID-19.
There is also the medicine “called Nasalferon — a derivative of Interferon — that is administered via the nose in drops, and this prevents the entry of the virus through the nasal passages,” explained García.
The Venezuelan head of state said that Cuba and Venezuela, the Bolivarian Alliance for the Peoples of Our America (ALBA), are making progress in the health of peoples, “putting the human being at the center.”
In this sense, he announced that this Monday, July 6, the new survey of the Homeland System will be launched, related to the diagnosis of the Coronavirus, “to inquire about COVID-19 issues in the Venezuelan family,” noting that the surveys that have used on the digital platform have been “highly useful”.
The goal “is to see the new stage, to what extent the “trocheros” (those entering the country using illegal trails) have infected the country, in order to detect any new outbreak that we might have not yet seen in the tests” and thus go to an “encircling methodology”.
“Let no one let their guard down!” emphasized the national president.
The president explained that this Sunday a new treatment protocol was also approved to advance early treatment, “the early treatment of all, for us to keep the people who have the Coronavirus in the best physical condition and that in Venezuela they are practically 100 percent hospitalized, receiving medical care.”
“This is not the case in the rest of the countries, fortunately we have the capacity of beds in public hospitals, private clinics, in Comprehensive Diagnostic Centers (CDI). Fortunately we have the installed capacity in the National Public Health System of Venezuela, to keep all cases hospitalized, 100 percent.”
Featured image: file photo.